SCHEMBL6034220

SCHEMBL6034220

CC(C)OC(=O)N1CC=Cc2ncccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 2/20 0.41
GRM1 Q13255 2/20 0.41
P2RX4 Q99571 1/20 0.39
BCHE P06276 1/20 0.39
MAPT P10636 2/20 0.35
LMNA P02545 1/20 0.35
GPR119 Q8TDV5 6/20 0.35
SLC6A15 Q9H2J7 1/20 0.34
SCN9A Q15858 1/20 0.34
SCN10A Q9Y5Y9 1/20 0.34
KDM4E B2RXH2 1/20 0.34
POLB P06746 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ALDH1A1 P00352 2/20 0.33
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NOTUM Q6P988 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28984504 0.82 POLB (0.43) GRM5GRM1BCHEGPR119POLB
SCHEMBL27770600 0.80 L3MBTL1 (0.34) MAPTLMNAKDM4EPOLBNPSR1
SCHEMBL4064728 0.79 MAPT (0.40) GRM5GRM1P2RX4BCHEMAPT
SCHEMBL22397495 0.79 MYC (0.36) MAPTLMNAKDM4EPOLBNPSR1
SCHEMBL6110761 0.78 P2RX4 (0.46) P2RX4BCHELMNASCN9ASCN10A
SCHEMBL16671338 0.77 PARP1 (0.36) LMNASCN9AKDM4ETSHRSMN1; SMN2
SCHEMBL5776879 0.77 P2RX4 (0.40) GRM5GRM1P2RX4BCHEMAPT
SCHEMBL13167123 0.71
SCHEMBL6033980 0.71 ALDH1A1 (0.42) GRM5GRM1P2RX4BCHEMAPT
SCHEMBL12671549 0.70 SMN1; SMN2 (0.33) MAPTLMNAKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1735320-A1 COMPOUNDS AND METHODS FOR TREATING DYSLIPIDEMIA ELI LILLY AND COMPANY (US) 2006-12-27 EP claimed
WO-2005097806-A1 COMPOUNDS AND METHODS FOR TREATING DYSLIPIDEMIA ELI LILLY AND COMPANY (US) 2005-10-20 WO claimed